Croda International Plc (LON:CRDA) insider Steve Foots purchased 3 shares of the business’s stock in a transaction on Monday, August 12th. The shares were bought at an average price of GBX 4,732 ($61.83) per share, for a total transaction of £141.96 ($185.50).
Steve Foots also recently made the following trade(s):
- On Wednesday, July 10th, Steve Foots purchased 3 shares of Croda International stock. The shares were bought at an average price of GBX 4,774 ($62.38) per share, for a total transaction of £143.22 ($187.14).
LON:CRDA opened at GBX 4,676 ($61.10) on Friday. The stock has a 50-day simple moving average of GBX 4,802.96 and a 200-day simple moving average of GBX 4,995.85. The stock has a market cap of $6.02 billion and a P/E ratio of 25.55. Croda International Plc has a 1 year low of GBX 4,499.12 ($58.79) and a 1 year high of GBX 5,460 ($71.34). The company has a debt-to-equity ratio of 78.01, a quick ratio of 0.93 and a current ratio of 1.74.
The firm also recently disclosed a dividend, which will be paid on Wednesday, October 2nd. Stockholders of record on Thursday, August 22nd will be given a dividend of GBX 39.50 ($0.52) per share. The ex-dividend date is Thursday, August 22nd. This represents a dividend yield of 0.85%. Croda International’s dividend payout ratio is currently 0.43%.
CRDA has been the subject of several analyst reports. UBS Group reaffirmed a “neutral” rating and set a GBX 5,100 ($66.64) price objective (down from GBX 5,500 ($71.87)) on shares of Croda International in a research report on Thursday, July 25th. JPMorgan Chase & Co. lowered their price objective on Croda International from GBX 4,800 ($62.72) to GBX 4,700 ($61.41) and set a “neutral” rating for the company in a research report on Friday, July 5th. Numis Securities reaffirmed a “hold” rating and set a GBX 4,750 ($62.07) price objective on shares of Croda International in a research report on Wednesday, May 29th. Credit Suisse Group upped their price objective on Croda International from GBX 3,900 ($50.96) to GBX 3,905 ($51.03) and gave the stock an “underperform” rating in a research report on Thursday, May 9th. Finally, Liberum Capital reaffirmed a “hold” rating on shares of Croda International in a research report on Wednesday, July 24th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of GBX 4,900.50 ($64.03).
About Croda International
Croda International Plc creates, makes, and sells specialty chemicals in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company operates in four segments: Personal Care, Life Sciences, Performance Technologies, and Industrial Chemicals. It offers adhesives; crop protection additives and adjuvants, seed enhancement and animal health chemicals, chemical bio-stimulants, and specialty additives for agricultural films; and lubricant additives, coatings and polymers, vehicle cleaning chemicals, and products for automotive textiles and fibers, as well as specialty additives for plastics, and battery and catalyst industries.
Further Reading: After-Hours Trading
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.